CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
6.83
-0.11 (-1.59%)
At close: Oct 30, 2026, 4:00 PM EDT
6.93
+0.10 (1.46%)
After-hours: Oct 30, 2026, 7:46 PM EDT
CapsoVision Revenue
CapsoVision had revenue of $3.64M in the quarter ending June 30, 2026, with 9.89% growth. This brings the company's total for the last twelve months to $13.89M, up 10.99% year-over-year. In the year 2025, CapsoVision had annual revenue of $13.55M with 15.29% growth. That makes CapsoVision the 35,805th largest company in the world by revenue and 4,710th in the United States.
Revenue (ttm)
$13.89M
Revenue Growth
+10.99%
P/S Ratio
24.61
Revenue / Employee
$140,313
Employees
99
Market Cap
341.82M
Revenue by Geography
- United States 10.66M 78.6%
- outside United States 2.90M 21.4%
Fiscal year ended Dec 31, 2025 See the full CapsoVision breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.55M | 1.80M | 15.29% |
| Dec 31, 2024 | 11.76M | 2.00M | 20.54% |
| Dec 31, 2023 | 9.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
CV News
- 2 days ago - CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026 - GlobeNewsWire
- 10 days ago - CapsoVision Transcript: LD Micro 20th Annual Main Event Conference - Transcripts
- 18 days ago - CapsoVision to Present at the 20th Annual LD Micro Main Event - GlobeNewsWire
- 23 days ago - CapsoVision Slides: Corporate presentation - Filings
- 4 weeks ago - CapsoVision announces FDA clearance of AI highlights for CapsoCam Plus - TheFly
- 4 weeks ago - CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus® - GlobeNewsWire
- 1 month ago - CapsoVision to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - CapsoVision resumed with a Buy at Roth Capital - TheFly